home All News open_in_new Full Article

Un fondo de Criteria lidera una ronda de tres millones en Adaptam Therapeutics

La compañía biotecnológica destinará los fondos obtenidos a seguir desarrollado sus distintos programas y a iniciar la fase preclínica de sus investigaciones en múltiples indicaciones oncológicas. Leer


today 34 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Society


ID: 473085857
Add Watch Country

arrow_drop_down